[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1021/bi00311a006; PubMed=6089875 [NCBI, ExPASy, EBI, Israel, Japan]
Kageyama R.,
Ohkubo H.,
Nakanishi S.;
"Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence.";
Biochemistry 23:3603-3609(1984).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2924688 [NCBI, ExPASy, EBI, Israel, Japan]
Gaillard I.,
Clauser E.,
Corvol P.;
"Structure of human angiotensinogen gene.";
DNA 8:87-99(1989).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=1692023 [NCBI, ExPASy, EBI, Israel, Japan]
Fukamizu A.,
Takahashi S.,
Seo M.S.,
Tada M.,
Tanimoto K.,
Uehara S.,
Murakami K.;
"Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.";
J. Biol. Chem. 265:7576-7582(1990).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-335.
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 1-338.
PubMed=2885106 [NCBI, ExPASy, EBI, Israel, Japan]
Kunapuli S.P.,
Kumar A.;
"Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart.";
Circ. Res. 60:786-790(1987).
|
[6]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 32-184.
DOI=10.1016/0003-9861(87)90148-2; PubMed=3579322 [NCBI, ExPASy, EBI, Israel, Japan]
Kunapuli S.P.,
Benedict C.R.,
Kumar A.;
"Tissue specific hormonal regulation of the rat angiotensinogen gene expression.";
Arch. Biochem. Biophys. 254:642-646(1987).
|
[7]
|
PROTEIN SEQUENCE OF 34-58.
DOI=10.1016/0006-291X(81)90762-2; PubMed=7259779 [NCBI, ExPASy, EBI, Israel, Japan]
Tewksbury D.A.,
Dart R.A.,
Travis J.;
"The amino terminal amino acid sequence of human angiotensinogen.";
Biochem. Biophys. Res. Commun. 99:1311-1315(1981).
|
[8]
|
PROTEIN SEQUENCE OF 34-45, AND SUBUNIT.
TISSUE=Serum;
DOI=10.1074/jbc.270.23.13645; PubMed=7539791 [NCBI, ExPASy, EBI, Israel, Japan]
Oxvig C.,
Haaning J.,
Kristensen L.,
Wagner J.M.,
Rubin I.,
Stigbrand T.,
Gleich G.J.,
Sottrup-Jensen L.;
"Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma.";
J. Biol. Chem. 270:13645-13651(1995).
|
[9]
|
PROTEIN SEQUENCE OF 34-43.
PubMed=4300938 [NCBI, ExPASy, EBI, Israel, Japan]
Arakawa K.,
Minohara A.,
Yamada J.,
Nakamura M.;
"Enzymatic degradation and electrophoresis of human angiotensin I.";
Biochim. Biophys. Acta 168:106-112(1968).
|
[10]
|
GLYCOSYLATION AT ASN-47; ASN-170; ASN-304 AND ASN-328.
DOI=10.1016/0303-7207(85)90039-5; PubMed=3934016 [NCBI, ExPASy, EBI, Israel, Japan]
Campbell D.J.,
Bouhnik J.,
Coezy E.,
Menard J.,
Corvol P.;
"Processing of rat and human angiotensinogen precursors by microsomal membranes.";
Mol. Cell. Endocrinol. 43:31-40(1985).
|
[11]
|
FUNCTION OF ANGIOTENSIN-3.
PubMed=1132082 [NCBI, ExPASy, EBI, Israel, Japan]
Goodfriend T.L.,
Peach M.J.;
"Angiotensin III: (DES-Aspartic Acid-1)-Angiotensin II. Evidence and speculation for its role as an important agonist in the renin - angiotensin system.";
Circ. Res. 36:38-48(1975).
|
[12]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-47, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[13]
|
DECARBOXYLATION AT ASP-34, FUNCTION, AND MASS SPECTROMETRY.
DOI=10.1161/01.ATV.0000253889.09765.5f; PubMed=17138938 [NCBI, ExPASy, EBI, Israel, Japan]
Jankowski V.,
Vanholder R.,
van der Giet M.,
Tolle M.,
Karadogan S.,
Gobom J.,
Furkert J.,
Oksche A.,
Krause E.,
Tran T.N.,
Tepel M.,
Schuchardt M.,
Schluter H.,
Wiedon A.,
Beyermann M.,
Bader M.,
Todiras M.,
Zidek W.,
Jankowski J.;
"Mass-spectrometric identification of a novel angiotensin peptide in human plasma.";
Arterioscler. Thromb. Vasc. Biol. 27:297-302(2007).
|
[14]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-47, AND MASS SPECTROMETRY.
TISSUE=Liver;
DOI=10.1021/pr8008012; PubMed=19159218 [NCBI, ExPASy, EBI, Israel, Japan]
Chen R.,
Jiang X.,
Sun D.,
Han G.,
Wang F.,
Ye M.,
Wang L.,
Zou H.;
"Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.";
J. Proteome Res. 8:651-661(2009).
|
[15]
|
STRUCTURE BY NMR OF ANGIOTENSIN-2.
DOI=10.1046/j.1432-1327.1998.2510448.x; PubMed=9492317 [NCBI, ExPASy, EBI, Israel, Japan]
Carpenter K.A.,
Wilkes B.C.,
Schiller P.W.;
"The octapeptide angiotensin II adopts a well-defined structure in a phospholipid environment.";
Eur. J. Biochem. 251:448-453(1998).
|
[16]
|
VARIANTS MET-207; THR-268 AND CYS-281.
DOI=10.1016/0092-8674(92)90275-H; PubMed=1394429 [NCBI, ExPASy, EBI, Israel, Japan]
Jeunemaitre X.,
Soubrier F.,
Kotelevtsev Y.V.,
Lifton R.P.,
Williams C.S.,
Charru A.,
Hunt S.C.,
Hopkins P.N.,
Williams R.R.,
Lalouel J.-M.,
Corvol P.;
"Molecular basis of human hypertension: role of angiotensinogen.";
Cell 71:169-180(1992).
|
[17]
|
VARIANT THR-268.
DOI=10.1038/ng0593-59; PubMed=8513325 [NCBI, ExPASy, EBI, Israel, Japan]
Ward K.,
Hata A.,
Jeunemaitre X.,
Helin C.,
Nelson L.,
Namikawa C.,
Farrington P.F.,
Ogasawara M.,
Suzumori K.,
Tomoda S.,
Berrebi S.,
Sasaki M.,
Corvol P.,
Lifton R.P.,
Lalouel J.-M.;
"A molecular variant of angiotensinogen associated with preeclampsia.";
Nat. Genet. 4:59-61(1993).
|
[18]
|
VARIANTS ILE-242; ARG-244 AND CYS-281.
DOI=10.1007/BF00214197; PubMed=7607642 [NCBI, ExPASy, EBI, Israel, Japan]
Hixson J.E.,
Powers P.K.;
"Detection and characterization of new mutations in the human angiotensinogen gene (AGT).";
Hum. Genet. 96:110-112(1995).
|
[19]
|
VARIANT PRE-ECLAMPSIA PHE-43.
DOI=10.1074/jbc.270.19.11430; PubMed=7744780 [NCBI, ExPASy, EBI, Israel, Japan]
Inoue I.,
Rohrwasser A.,
Helin C.,
Jeunemaitre X.,
Crain P.,
Bohlender J.,
Lifton R.P.,
Corvol P.,
Ward K.,
Lalouel J.-M.;
"A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system.";
J. Biol. Chem. 270:11430-11436(1995).
|
[20]
|
CHARACTERIZATION OF VARIANT CYS-281.
DOI=10.1074/jbc.271.16.9838; PubMed=8621667 [NCBI, ExPASy, EBI, Israel, Japan]
Gimenez-Roqueplo A.P.,
Leconte I.,
Cohen P.,
Simon D.,
Guyene T.T.,
Celerier J.,
Pau B.,
Corvol P.,
Clauser E.,
Jeunemaitre X.;
"The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein.";
J. Biol. Chem. 271:9838-9844(1996).
|
[21]
|
VARIANT RTD GLN-375.
DOI=10.1038/ng1623; PubMed=16116425 [NCBI, ExPASy, EBI, Israel, Japan]
Gribouval O.,
Gonzales M.,
Neuhaus T.,
Aziza J.,
Bieth E.,
Laurent N.,
Bouton J.M.,
Feuillet F.,
Makni S.,
Ben Amar H.,
Laube G.,
Delezoide A.-L.,
Bouvier R.,
Dijoud F.,
Ollagnon-Roman E.,
Roume J.,
Joubert M.,
Antignac C.,
Gubler M.-C.;
"Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis.";
Nat. Genet. 37:964-968(2005).
|
|
ExPASy Home page
SIB Switzerland
